Primasol Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 50.00 K
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 29.21%
- Profit Growth 37.48%
- Ebitda 25.19%
- Net Worth 35.34%
- Total Assets 72.37%
About Primasol Pharmaceutical
Primasol Pharmaceutical Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2019 (Five years and five months 5 days old ). Its registered office is in Dibrugarh, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sushanta Boruah and Monjula Phukan serve as directors at the Company.
Company Details
-
Location
Dibrugarh, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52311AS2019PTC019488
-
Company No.
019488
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Sep 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Primasol Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushanta Boruah
|
Director | 02-Sep-2019 | Current |
|
Monjula Phukan
|
Director | 02-Sep-2019 | Current |
Financial Performance of Primasol Pharmaceutical.
Primasol Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.21% increase. The company also saw a substantial improvement in profitability, with a 37.48% increase in profit. The company's net worth Soared by an impressive increase of 35.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Primasol Pharmaceutical?
Unlock access to Primasol Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ranamita Medical Services (Opc) Private LimitedSushanta Boruah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Primasol Pharmaceutical?
Unlock and access historical data on people associated with Primasol Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Primasol Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primasol Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.